- Home
- ALGS vs LRFC Comparison
ALGS vs LRFC Comparison
Compare ALGS & LRFC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- ALGS
- LRFC
- Stock Information
- Founded
- ALGS 2018
- LRFC 2013
- Country
- ALGS United States
- LRFC United States
- Employees
- ALGS N/A
- LRFC N/A
- Industry
- ALGS Biotechnology: Pharmaceutical Preparations
- LRFC Finance: Consumer Services
- Sector
- ALGS Health Care
- LRFC Finance
- Exchange
- ALGS Nasdaq
- LRFC Nasdaq
- Market Cap
- ALGS 50.4M
- LRFC 50.2M
- IPO Year
- ALGS 2020
- LRFC 2013
- Fundamental
- Price
- ALGS $7.84
- LRFC $18.81
- Analyst Decision
- ALGS Strong Buy
- LRFC
- Analyst Count
- ALGS 1
- LRFC 0
- Target Price
- ALGS $70.00
- LRFC N/A
- AVG Volume (30 Days)
- ALGS 125.8K
- LRFC 11.1K
- Earning Date
- ALGS 08-05-2025
- LRFC 08-07-2025
- Dividend Yield
- ALGS N/A
- LRFC 7.60%
- EPS Growth
- ALGS N/A
- LRFC N/A
- EPS
- ALGS N/A
- LRFC N/A
- Revenue
- ALGS $3,270,000.00
- LRFC $20,544,000.00
- Revenue This Year
- ALGS N/A
- LRFC N/A
- Revenue Next Year
- ALGS $51.55
- LRFC N/A
- P/E Ratio
- ALGS N/A
- LRFC N/A
- Revenue Growth
- ALGS N/A
- LRFC 3.11
- 52 Week Low
- ALGS $3.76
- LRFC $16.57
- 52 Week High
- ALGS $46.80
- LRFC $26.00
- Technical
- Relative Strength Index (RSI)
- ALGS 57.02
- LRFC 56.96
- Support Level
- ALGS $6.82
- LRFC $18.51
- Resistance Level
- ALGS $8.66
- LRFC $19.06
- Average True Range (ATR)
- ALGS 0.76
- LRFC 0.39
- MACD
- ALGS -0.06
- LRFC 0.12
- Stochastic Oscillator
- ALGS 55.49
- LRFC 84.90
About ALGS Aligos Therapeutics Inc.
Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.
About LRFC Logan Ridge Finance Corporation
Logan Ridge Finance Corp an externally managed non-diversified closed-end management investment company. Its investment objective is to generate both current income and capital appreciation through debt and equity investments. The company offers customized financing to business owners, management teams, and financial sponsors for change of ownership transactions, recapitalizations, strategic acquisitions, business expansion, and other growth initiatives.